KR840001175A - Method for preparing [3H] -imidazo [5,1-d] -1,2,3,5-tetrazin-4-one derivative - Google Patents

Method for preparing [3H] -imidazo [5,1-d] -1,2,3,5-tetrazin-4-one derivative Download PDF

Info

Publication number
KR840001175A
KR840001175A KR1019820003774A KR820003774A KR840001175A KR 840001175 A KR840001175 A KR 840001175A KR 1019820003774 A KR1019820003774 A KR 1019820003774A KR 820003774 A KR820003774 A KR 820003774A KR 840001175 A KR840001175 A KR 840001175A
Authority
KR
South Korea
Prior art keywords
group
formula
carbon atoms
derivative
producing
Prior art date
Application number
KR1019820003774A
Other languages
Korean (ko)
Other versions
KR890000094B1 (en
Inventor
런트 에드워어드 (외 3)
Original Assignee
더글라스 델림플 렘지 시벌드
메이 앤드 베이커 리미팃드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더글라스 델림플 렘지 시벌드, 메이 앤드 베이커 리미팃드 filed Critical 더글라스 델림플 렘지 시벌드
Publication of KR840001175A publication Critical patent/KR840001175A/en
Application granted granted Critical
Publication of KR890000094B1 publication Critical patent/KR890000094B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Abstract

내용 없음No content

Description

[3H]-이미다조 [5,1-d]-1,2,3,5-테트라진-4-온 유도체의 제조방법Method for preparing [3H] -imidazo [5,1-d] -1,2,3,5-tetrazin-4-one derivative

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (15)

하기 구조식(Ⅱ)의 화합물과 하기 구조식(Ⅲ)의 이소시아네이트와 반응시켜 하기 구조식(Ⅰ)의 [3H]-이미다조 [5,1-d]-1,2,3,5-테트라진-4-온 유도체를 제조하는 방법.[ 3H ] -imidazo [5,1-d] -1,2,3,5-tetrazine- of Structural Formula (I) by reacting a compound of Structural Formula (II) with an isocyanate of Structural Formula (III) Process for preparing 4-one derivatives. . . 상기 식에서, R1은 할로겐원자, 탄소수 1-4인 직쇄 알콕시, 알킬티오, 알킬설피닐 및 알킬설포닐기 및 선택적으로 치환된 페닐기로부터 선정된 1-3의 치환체에 의해 치환되거나 치환되지 않은 탄소수 1-6의 직쇄 또는 측쇄알킬, 알케닐 또는 알키닐기 및 탄소수 3-8의 시클로알킬기이고; R2는 탄소수가 1-4인 직쇄 및 측쇄 알킬 및 알케닐기와 탄소수 3-8의 시클로알킬기로부터 선정된 1 또는 2개의 원자단이 질소에 결합된 카르바모일기이며, R3는 할로겐원자, 탄소수 1-4인 직쇄 또는 측쇄알콕시, 알킬티오, 알킬설피닐 및 알킬설포닐기와 선택적으로 치환된 페닐기로부터 선정된 1-3의 치환체에 의해 치환되거나 치환되지 않은 탄소수 1-6의 직쇄 또는 측쇄알킬, 알케닐 또는 알키닐기, 또는 탄소수 3-8의 시클로알킬이다.Wherein R 1 is unsubstituted or substituted by 1-3 substituents selected from halogen atoms, straight alkoxy, alkylthio, alkylsulfinyl and alkylsulfonyl groups having 1-4 carbon atoms and optionally substituted phenyl groups; A -6 straight or branched chain alkyl, alkenyl or alkynyl group and a C3-8 cycloalkyl group; R 2 is a carbamoyl group in which one or two atom groups selected from straight and branched chain alkyl and alkenyl groups having 1 to 4 carbon atoms and cycloalkyl groups having 3 to 8 carbon atoms are bonded to nitrogen, and R 3 is a halogen atom, 1 carbon atom Straight or branched chain alkyl of 1 to 6 carbon atoms, unsubstituted or substituted by a substituent of 1-3 selected from a straight or branched alkoxy, alkylthio, alkylsulfinyl and alkylsulfonyl group optionally substituted with -4; A kenyl or alkynyl group or cycloalkyl having 3-8 carbon atoms. 하기 구조식(Ⅳ)의 화합물 또는 그의 알칼리 금속염을 하기 구조식(Ⅴ)의 화합물과 반응시켜 상기 구조식(Ⅰ)의 [3H]-이미다조 [5,1-d]-1,2,3,5-테트라진-4-온 유도체를 제조하는 방법.[ 3H ] -imidazo [5,1-d] -1,2,3,5 of formula (I) by reacting a compound of formula (IV) or an alkali metal salt thereof with a compound of formula (V) To prepare a tetrazin-4-one derivative. R3X VR 3 XV 상 식에서, R1,R2,R3는 상기에서 규정한 바와 같고, X는 반응성 에스테르의 산잔류기이다.Wherein R 1 , R 2 , R 3 are as defined above and X is the acid residue of the reactive ester. 제2항에 있어서, X가 할로겐원자, 메톡시설포닐옥시기, 메탄설포닐옥시기, 또는 톨루엔-P-설포닐옥시기인 것을 특징으로 하는 상기 구조식(Ⅰ) 화합물의 제조방법.The method for producing the compound of formula (I) according to claim 2, wherein X is a halogen atom, a methoxysulfonyloxy group, a methanesulfonyloxy group, or a toluene- P -sulfonyloxy group. 하기 구조식(Ⅱ)의 화합물을 하기 구조식(Ⅵ)의 화합물과 반응시킨 다음, 하기 구조식 R4가 보호기일 때 얻어지는 하기 구조식(Ⅶ) 화합물중 보호기를 공지 방법에 의해 수소원자로 치환하므로써 R1이 수소원자이고 R2가 상기 규정한 바와 같은 구조식(Ⅰ)의 [3H]-이미다조-[5,1-d]-1,2,3,5-테트라진-4-온 유도체 및 그의 알카리 금속염을 제조하는 방법.After reacting a compound of formula (II) with a compound of formula (VI), R 1 represents hydrogen by substituting a hydrogen atom by a known method for protecting groups in the compound of formula (VII) obtained when R 4 is a protecting group [3H] -imidazo- [5,1-d] -1,2,3,5-tetrazin-4-one derivative of the formula (I) wherein R 2 is an atom and an alkali metal salt thereof How to manufacture. 상기 식에서, R2는 청구범위 1에서와 같으며, R4는 알카리 금속 원자 또는 보호기 (예, 벤질 또는 P-메톡시벤질기)이고, R5는 벤질 또는 P-메톡시벤질기 같은 보호기이다.Wherein R 2 is as in Claim 1, R 4 is an alkali metal atom or protecting group (eg benzyl or P-methoxybenzyl group), and R 5 is a protecting group such as benzyl or P-methoxybenzyl group . 제1항, 2항 또는3항에 있어서, R1이 1-3개의 선택적으로 치환된 페닐기에 의해 치환된 알킬, 알케닐 또는 알키닐기이고, 페닐라디칼중의 선택적 치환체가 탄소수 1-4를 갖는 알콕시기, 알킬기 및 니트로기로부터 선정되는 것을 특징으로 하는 구조식의 테트라진 유도체를 제조하는 방법.The compound according to claim 1, 2 or 3, wherein R 1 is an alkyl, alkenyl or alkynyl group substituted by 1-3 optionally substituted phenyl groups, and the optional substituent in the phenyl radical has 1 to 4 carbon atoms. Method for producing a tetrazine derivative of the formula characterized in that it is selected from an alkoxy group, an alkyl group and a nitro group. 제1항, 2항 또는 3항에 있어서, R1이 탄소수 1-4를 갖는 1 또는 2의 알콕시기에 의해 선택적으로 치환된 페닐기, 탄소수 1-4를 갖는 알콕시기 또는 1 또는 그의 할로겐원자로 선택 치환되고 탄소수 1-6을 갖는 직쇄 또는 측쇄 알킬기, 탄소수 2-6인 알케닐기, 또는 시클로헥실기인 상기 구조식(Ⅰ)의 테트라진 유도체를 제조하는 방법.According to claim 1, 2 or 3 wherein R 1 is selected, an alkoxy group or one or a halogen atom having an optionally substituted phenyl group, having 1 to 4 carbons substituted by alkoxy groups of 1 or 2 having a carbon number of 1 to 4 substituted And a straight or branched chain alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, or a cyclohexyl group. 제6항에 있어서, 할로겐 원자가 염소, 불소 및 또는 브롬이고, 알콕시기가 메톡시이며, 알케닐기가 알릴인 것을 특징으로 하는 방법.7. A process according to claim 6, wherein the halogen atoms are chlorine, fluorine and or bromine, the alkoxy group is methoxy and the alkenyl group is allyl. 제1항, 2항, 또는 3항에 있어서, R1이할로겐원자로 치환되거나 치환되지 않은 탄소수 1-6의 직쇄 또는 측쇄 알킬기인 것을 특징으로 하는 상기 구조식(Ⅰ)의 테트라진 유도체를 제조하는 방법.The method for producing the tetrazine derivative of the above formula (I) according to claim 1, 2 or 3, wherein R 1 is a linear or branched alkyl group having 1 to 6 carbon atoms which is substituted or unsubstituted with a halogen atom. . 제1항, 2항 또는 3항에 있어서, R1이 할로겐원자로 치환되거나 치환되지 않은 탄소수 1-3의 알킬기인 것을 특징으로 하는 상기 구조식(Ⅰ)의 테트라진 유도체 를 제조하는 방법.The method for preparing the tetrazine derivative of the above formula (I) according to claim 1, 2 or 3, wherein R 1 is an alkyl group having 1 to 3 carbon atoms substituted or unsubstituted with a halogen atom. 제1항, 2항 또는 3항에 있어서, R1이 메틸기 또는 2-할로알킬기인 것을 특징으로 하는 상기 구조식(Ⅰ)의 테트라진 유도체를 제조하는 방법.The process for producing the tetrazine derivative of formula (I) according to claim 1, 2 or 3, wherein R 1 is a methyl group or a 2-haloalkyl group. 제10항에 있어서, 알킬기중의 할로겐원자가 염소 또는 불소인 것을 특징으로 하는 상기 구조식(Ⅰ)의 테트라진 유도체를 제조하는 방법.The process for producing the tetrazine derivative of formula (I) according to claim 10, wherein the halogen atom in the alkyl group is chlorine or fluorine. 제1항, 2항 또는 3항에 있어서, R1이 2-플루오로에틸 또는 2-클로로에틸기인 것을 특징으로 하는 상기 구조식(Ⅰ)의 테트라진 유도체를 제조하는 방법.The process for producing the tetrazine derivative of formula (I) according to claim 1, 2 or 3, wherein R 1 is a 2-fluoroethyl or 2-chloroethyl group. 제1항, 2항 또는 3항에 있어서, R1이 벤질 또는P-메톡시벤질기인 것을 특징으로 하는 상기 구조식(Ⅰ)의 테트라진 유도체를 제조하는 방법.The process for producing the tetrazine derivative of formula (I) according to claim 1, 2 or 3, wherein R 1 is a benzyl or P -methoxybenzyl group. 제1항 내지 제13항중 어느 하나에 있어서, 청구범위 1항에서 명시한 구조식(Ⅰ)의 테트라진 생성물 중 R2가 카르바모일기, 알킬기에 탄소수 1-4를 갖는 모노알킬카르바모일기, 또는 알케닐기에 탄소수 1-4를 갖는 모노알케닐카르바모일기인 것을 특징으로 하는 테트라진 유도체의 제조방법.The monoalkylcarbamoyl group according to any one of claims 1 to 13, wherein R 2 in the tetrazine product of formula (I) specified in claim 1 has a carbamoyl group, an alkyl group having 1 to 4 carbon atoms, or an egg. A method for producing a tetrazine derivative, wherein the kenyl group is a monoalkenylcarbamoyl group having 1 to 4 carbon atoms. 제1항, 2항 또는 3항에 있어서, R1이 1-3의 할로겐원자로 치환되거나 치환되지 않은 탄소수 1-6의 직쇄 또는 측쇄알킬, 알케닐 또는 알키닐기인 것을 특징으로 하는 상기 구조식(Ⅰ)의 테트라진 유도체를 제조하는 방법.The structural formula (I) according to claim 1, 2 or 3, wherein R 1 is a linear or branched alkyl, alkenyl or alkynyl group having 1 to 6 carbon atoms which is optionally substituted with a halogen atom of 1-3. To prepare a tetrazine derivative. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR8203774A 1981-08-24 1982-08-23 Process for preparing 3h-imidazo 5,1-d-1,2,3,5-tetrazine-4-one derivatives KR890000094B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8125791 1981-08-24
GB8125791 1981-08-24
GB81-25791 1981-08-24

Publications (2)

Publication Number Publication Date
KR840001175A true KR840001175A (en) 1984-03-28
KR890000094B1 KR890000094B1 (en) 1989-03-07

Family

ID=10524141

Family Applications (1)

Application Number Title Priority Date Filing Date
KR8203774A KR890000094B1 (en) 1981-08-24 1982-08-23 Process for preparing 3h-imidazo 5,1-d-1,2,3,5-tetrazine-4-one derivatives

Country Status (29)

Country Link
JP (1) JPS5843975A (en)
KR (1) KR890000094B1 (en)
AT (1) AT380256B (en)
AU (1) AU571430B2 (en)
BE (1) BE894175A (en)
CA (1) CA1197247A (en)
CH (1) CH655114A5 (en)
DE (2) DE19975037I2 (en)
DK (1) DK161147C (en)
ES (1) ES8400438A1 (en)
FI (1) FI73434C (en)
FR (1) FR2511679A1 (en)
GB (1) GB2104522B (en)
GE (1) GEP19960641B (en)
GR (1) GR76863B (en)
HU (1) HU186107B (en)
IE (1) IE53408B1 (en)
IL (1) IL66606A (en)
IT (1) IT1152505B (en)
LT (1) LT2436B (en)
LU (1) LU84347A1 (en)
LV (2) LV5511A3 (en)
NL (2) NL192739C (en)
NZ (1) NZ201668A (en)
OA (1) OA07174A (en)
SE (1) SE448543B (en)
SU (1) SU1447284A3 (en)
UA (1) UA5971A1 (en)
ZA (1) ZA826120B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260291A (en) * 1981-08-24 1993-11-09 Cancer Research Campaign Technology Limited Tetrazine derivatives
FR2531958B1 (en) * 1982-08-17 1986-10-31 May & Baker Ltd NEW DERIVATIVES
GB2125402B (en) * 1982-08-17 1985-11-13 May & Baker Ltd New tetrazine derivatives
US4517182A (en) * 1983-05-24 1985-05-14 Warner-Lambert Company 3-(Haloethyl)-4-oxopyrazolo-[5,1-d]-1,2,3,5-tetrazine-8-carboxamide composition
GB8616125D0 (en) * 1986-07-02 1986-08-06 May & Baker Ltd Compositions of matter
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
EP1706407A2 (en) * 2003-12-30 2006-10-04 Chemagis Ltd. Novel crystalline forms of temozolomide
ES2552338T3 (en) 2005-01-21 2015-11-27 Astex Therapeutics Limited Pharmaceutical compounds
AR060635A1 (en) 2006-04-27 2008-07-02 Banyu Pharma Co Ltd DERIVATIVES OF 1,2-DIHIDRO-3H-PIRAZOLO [3,4-D] PIRIMIDIN-3-ONA, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THEIR USE IN THE TREATMENT OF CANCER
JP2008081492A (en) 2006-08-31 2008-04-10 Banyu Pharmaceut Co Ltd New aminopyridine derivative having aurora a selective inhibitory action
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
AU2008315048A1 (en) 2007-10-23 2009-04-30 Msd K.K. Pyridone-substituted-dihydropyrazolopyrimidinone derivative
PE20091101A1 (en) 2007-12-18 2009-07-26 Pharminox Ltd 3-SUBSTITUTED-4-OXO-3,4-DIHYDRO-IMIDAZO [5,1-d] [1,2,3,5-TETRACINE-8-CARBOXYL ACID AMIDES AND ITS USE
EP2367828B1 (en) * 2008-11-24 2014-06-11 Reliance Life Sciences Pvt., Ltd. Process for the preparation of tetrazine derivatives
EP2403339B1 (en) 2009-03-06 2017-01-18 Merck Sharp & Dohme Corp. Combination cancer therapy with an akt inhibitor and other anticancer agents
JP2012530775A (en) 2009-06-23 2012-12-06 ファーミノックス リミテッド 3-substituted-8-substituted-3H-imidazo [5,1-d] [1,2,3,5-tetrazin-4-one compounds and uses thereof
RU2462466C1 (en) * 2011-06-24 2012-09-27 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Substituted azolo[1,2,4,5]tetrazines - inhibitors of antibacterial serine-threonine protein kinases
US20140271657A1 (en) 2011-10-12 2014-09-18 Children's Medical Center Corporation Combinatorial compositions and methods of treating hemoglobinopathies
EA201892075A1 (en) 2016-03-15 2019-04-30 Оризон Дженомикс, С.А. COMBINATION OF LSD1 INHIBITORS FOR USE FOR THE TREATMENT OF SOLID TUMORS
KR101847342B1 (en) * 2017-05-08 2018-04-11 (주)센텍코리아 Wearable body fat burning measurement device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2932305A1 (en) * 1979-08-09 1981-02-26 Basf Ag Pyrrolo-, pyrazolo-, imidazo- and thiazolo-tetrazin-4-one derivs. - prepd. from amino-azole cpds. by diazotisation and reaction with isocyanate

Also Published As

Publication number Publication date
KR890000094B1 (en) 1989-03-07
DE19975037I2 (en) 2001-06-13
FI822921L (en) 1983-02-25
DK161147C (en) 1991-11-18
NL192739B (en) 1997-09-01
ES515176A0 (en) 1983-11-01
FI73434B (en) 1987-06-30
OA07174A (en) 1984-04-30
FR2511679A1 (en) 1983-02-25
UA5971A1 (en) 1994-12-29
DK377882A (en) 1983-02-25
NL990010I2 (en) 1999-09-01
BE894175A (en) 1983-02-23
LV5511A3 (en) 1994-03-10
JPH045029B2 (en) 1992-01-30
NL990010I1 (en) 1999-07-01
LT2436B (en) 1994-02-15
GR76863B (en) 1984-09-04
GB2104522A (en) 1983-03-09
NZ201668A (en) 1985-08-16
LV5621A3 (en) 1994-05-10
IT1152505B (en) 1987-01-07
IL66606A (en) 1987-07-31
DK161147B (en) 1991-06-03
ATA319182A (en) 1985-09-15
AU571430B2 (en) 1988-04-21
HU186107B (en) 1985-06-28
FI822921A0 (en) 1982-08-23
IT8222938A0 (en) 1982-08-23
DE3231255A1 (en) 1983-03-03
JPS5843975A (en) 1983-03-14
SE8204817L (en) 1983-02-25
NL192739C (en) 1998-01-06
CH655114A5 (en) 1986-03-27
ES8400438A1 (en) 1983-11-01
IE822026L (en) 1983-02-24
LU84347A1 (en) 1983-06-07
IE53408B1 (en) 1988-11-09
IL66606A0 (en) 1982-12-31
SE448543B (en) 1987-03-02
SE8204817D0 (en) 1982-08-23
GEP19960641B (en) 1996-11-15
DE3231255C2 (en) 1992-02-27
FR2511679B1 (en) 1985-02-01
NL8203286A (en) 1983-03-16
CA1197247A (en) 1985-11-26
SU1447284A3 (en) 1988-12-23
GB2104522B (en) 1985-06-12
FI73434C (en) 1987-10-09
ZA826120B (en) 1983-07-27
AT380256B (en) 1986-05-12
AU8749382A (en) 1983-03-03

Similar Documents

Publication Publication Date Title
KR840001175A (en) Method for preparing [3H] -imidazo [5,1-d] -1,2,3,5-tetrazin-4-one derivative
ES8206443A1 (en) Novel amidine compounds, process for producing same and anti-complement agent comprising them.
KR870003998A (en) Method for preparing quinazoline derivatives
KR940007034A (en) Method for preparing 5-substituted pyrrolo [2,3-di] pyrimidine
AU8891091A (en) Preparation and use of n-iodopropargyl oxycarbonyl amino acid esters and derivatives as antimicrobial agents
KR860008976A (en) 2- (4-benzoyl-1-piperidyl) -1-phenylalkanol derivative
NO301543B1 (en) 2- £ 4- (quinazolinylmethylamino) benzamido | -4- (tetrazolyl) butyric acid derivatives with anti-tumor activity
ATE2079T1 (en) 8-PHENYL PURINES, THEIR MANUFACTURE AND PHARMACEUTICALS CONTAINING THEM.
KR850008488A (en) Method for preparing dihydroimidazo [1,2-a] pyrimidine derivatives
ES543154A0 (en) METHOD OF PREPARING A B-CARBOLIN-3-CARBO- XYLIC ACID DERIVATIVE
NO852091L (en) PROCEDURE FOR THE PREPARATION OF ALKALOIDS.
ES2053896T3 (en) 4,5-DIARILTIOIMIDAZOLES 2-SUBSTITUTED ANTI-HYPERCHOLESTEROLESMIC.
ES516361A0 (en) "PROCEDURE FOR THE PREPARATION OF A DIISOCIANATO".
DE69118744D1 (en) Lubricating oil additives, their manufacture and their use
KR870002126A (en) Method for preparing tetrahydroquinolin-1-yl carbonyl imidazole derivative
KR850002094A (en) Method for preparing naphthalenyl imidazopyridine and derivatives thereof
ES8703401A1 (en) Process for the preparation of esters of 4-acyloxy-3-keto-butyric acid.
ES8308870A1 (en) 5-(4-Phenyl-1-piperidinyl)methyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives.
ES8305377A1 (en) Nitrosourea derivatives, a process for preparing same and therapeutic compositions.
KR840000578A (en) Process for preparing phospholipid derivative
AU3775085A (en) Synthesis of esters
KR860000296A (en) Method for preparing isooxazoloquirollinone derivative
KR850003537A (en) Method for preparing substituted 2-imino-3,4,6,7-tetrahydro-4H-pyrimido [6,1-a] isoquinolin-4-one
KR830001935A (en) Preparation of new 4-aryl-5,6,7,8-tetrahydro pyrazolo (3,4b)diazepine-1H,4H-5,7-diones and pharmaceuticals containing these compounds
KR860009016A (en) Method for producing an antivirus compound